---
title: "New Drugs Offer Hope Against Super‑Resistant Gonorrhoea"
summary: "Scientists have approved two new medicines—zoliflodacin and gepotidacin—to treat gonorrhoea that no longer responds to usual drugs. The infections are rising worldwide, especially in Africa and the Western Pacific, and resistance to common antibiotics has jumped from less than 1 % to over 5 % in recent years. Trials show zoliflodacin cures more than 90 % of cases with a single oral pill, offering a simpler, safer option that could curb resistance."
category: General News
section: "Global development"
imageUrl: "https://media.guim.co.uk/47c5913a19041d4a74ca4606c3dd6c3c415b1746/500_0_2624_2100/500.jpg"
publishedAt: "2025-12-16T05:00:13Z"
guardianId: "global-development/2025/dec/16/health-antibiotic-resistance-drugs-superbugs-sexually-transmitted-gonorrhoea"
---

Scientists have approved two new medicines—zoliflodacin and gepotidacin—to treat gonorrhoea that no longer responds to usual drugs. The infections are rising worldwide, especially in Africa and the Western Pacific, and resistance to common antibiotics has jumped from less than 1 % to over 5 % in recent years. Trials show zoliflodacin cures more than 90 % of cases with a single oral pill, offering a simpler, safer option that could curb resistance.
